Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Park Y, Tantry US, Koh JS, Ahn JH, Kang MG, Kim KH, Jang JY, Park HW, Park JR, Hwang SJ, Park KS, Kwak CH, Hwang JY, Gurbel PA, Jeong YH. Park Y, et al. Among authors: park hw, park jr, park ks. Thromb Haemost. 2017 May 3;117(5):911-922. doi: 10.1160/TH16-10-0744. Epub 2017 Feb 2. Thromb Haemost. 2017. PMID: 28150852
Cytochrome 2C19 polymorphism and response to adjunctive cilostazol versus high maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention.
Hwang SJ, Jeong YH, Kim IS, Park KS, Kang MK, Koh JS, Park JR, Park Y, Koh EH, Kwak CH, Hwang JY, Kim S. Hwang SJ, et al. Among authors: park y, park ks, park jr. Circ Cardiovasc Interv. 2010 Oct;3(5):450-9. doi: 10.1161/CIRCINTERVENTIONS.110.949859. Epub 2010 Sep 7. Circ Cardiovasc Interv. 2010. PMID: 20823393 Clinical Trial.
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Kim IS, Jeong YH, Park Y, Park KS, Yun SE, Park JR, Hwang SJ, Koh EH, Kwak CH, Hwang JY, Kim S. Kim IS, et al. Among authors: park y, park ks, park jr. JACC Cardiovasc Interv. 2011 Apr;4(4):381-91. doi: 10.1016/j.jcin.2010.12.010. JACC Cardiovasc Interv. 2011. PMID: 21511217 Free article. Clinical Trial.
Efficacy of cilostazol on inhibition of platelet aggregation, inflammation and myonecrosis in acute coronary syndrome patients undergoing percutaneous coronary intervention: The ACCEL-LOADING-ACS (ACCELerated Inhibition of Platelet Aggregation, Inflammation and Myonecrosis by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome) study.
Lee K, Yoo SY, Suh J, Park KH, Park Y, Tantry US, Park KS, Han SH, Kang WC, Shin DH, Lee C, Choi SW, Lee JH, Cho YH, Lee NH, Jeong MH, Ahn Y, Kubica J, Gurbel PA, Park JH, Jeong YH. Lee K, et al. Among authors: park jh, park kh, park y, park ks. Int J Cardiol. 2015;190:370-5. doi: 10.1016/j.ijcard.2015.04.180. Epub 2015 Apr 23. Int J Cardiol. 2015. PMID: 25956540 Clinical Trial. No abstract available.
3,442 results